Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009–2010)

Abstract

On an average, non-commercial trial protocols were associated with a small per patient excess treatment cost, whereas commercial trials were associated with a substantially higher cost saving. Taking into account the total number of patients recruited annually, treatment of patients on clinical trial protocols was associated with considerable cost savings across both the non-commercial and commercial portfolio.